explore -WSS

explore

author：hotspot 2025-09-14 21:56:17 - browse：4633

Akero Therapeutics said Tuesday that an experimental medicine failed to show a significant benefit for patients with cirrhosis caused by NASH, the most advanced and life-threatening stage of the fatty liver disease.

While the study’s primary goal of improving liver fibrosis, or scarring, was not achieved, the Akero drug, called efruxifermin, outperformed placebo by 10 percentage points. The drug also resolved NASH symptoms, including reductions in liver fat and inflammation, and improved other markers of the disease.

“These are the best data reported to date for any NASH drug in this patient population,” said Kitty Yale, Akero’s chief development officer. “We missed the primary endpoint. We understand that, but there’s actually a lot of hope when you look at the totality of the data.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： What we need to know about Arena Bioworks

WSS

The stability of $0 premiums in Medicare Advantage

6 solutions to address cancer drug shortages and others

Medicare innovation center doesn’t save money, experts say

A $475,000 price tag for a new cancer drug: crazy or meh?

What will Novo Nordisk's VC do with its influx of cash?

Some dementia cases could be undiagnosed liver disease

knowledge

explore

focus

23andMe had bad news about my health. I wish a person had delivered it

Some dementia cases could be undiagnosed liver disease

Cancer drug shortages should be causing more outrage

Stop Congress from blocking public access to science

Alkermes shareholders re

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Congress extends some pandemic preparedness programs

focus

New oral drug delivery patch is modeled after octopus tentacles

A $475,000 price tag for a new cancer drug: crazy or meh?

6 solutions to address cancer drug shortages and others

CDC picks Alphabet's Verily for wasterwater surveillance contract

Lawsuit highlights wrinkle for disputes over surprise medical bills

Juul spent big to court Black leaders to promote its e

knowledge

hotspot

hotspot

focus